Immune Catalyst contains a comprehensive formulation containing a synergistic blend of nutrient and botanical ingredients designed to decrease inflammation and increase mucociliary clearance during sinus and respiratory challenges. The ingredients are enclosed in the acid-resistant capsule (DRcaps™) to ensure efficacious delivery into the bloodstream for therapeutic benefits.
Thyme Leaf Powder – A powerful herb that helps to relieve coughs, loosen phlegm and to soothe sinuses.*
Andrographis Leaf Extract – Recent studies show that Andrographis can significantly reduce the severity, duration and symptoms of the common cold.*
Bromelain – Anti-inflammatory agent used to reduce sinus inflammation, pressure, and pain.*
Eucalyptus Powder - A powerful herb with potent anti-inflammatory, antiparastic, antifungal, antiviral and antibacterial properties.*
Eleuthero Root Extract - An adaptogenic herb that supports immune function, especially in combination with andrographis.*
|
* These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease. |
Suggested Use:
As a dietary supplement, for acute concerns, take two (2) capsules on an empty stomach three times daily for 4-7 days or until symptoms subside; for chronic concerns, take 2 capsules once a day for up to 30 days or as recommended by your health care professional.
Caution:
Do not take this product if you are pregnant or nursing or if you have a pineapple allergy. As with any dietary supplement, consult your healthcare practitioner before using this product, especially if you anticipate surgery, take any medication (especially blood thinners, anti-platelet medications, and tetracycline antibiotics) or are otherwise under medical supervision.
Formulated To Be Free of Allergens Derived From:
Wheat, soy, milk, artificial preservatives, sweeteners, colors and flavors.
* These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
National Institute of Allergy and Infectious Diseases
Anand, V., Ann Otol Rhinol Laryngol Suppl 113:2004
Anand, V., Ann Otol Rhinol Laryngol Suppl 113:2004, inflation adjusted
Prevent the Common Cold. (2017). Centers for Disease Control and Prevention. Retrieved 26 January 2017, from https://www.cdc.gov/features/rhinoviruses/
American Academy of Otolaryngology – Head and Neck Surgery
Juergens, U. R., Dethlefsen, U., Steinkamp, G., Gillissen, A., Repges, R., & Vetter, H. (2003). Anti-inflammatory activity of 1.8-cineol (eucalyptol) in bronchial asthma: a double-blind placebo-controlled trial. Respiratory medicine, 97(3), 250-256.
Tesche, S., Metternich, F., Sonnemann, U., Engelke, J. C., & Dethlefsen, U. (2008). The value of herbal medicines in the treatment of acute non-purulent rhinosinusitis. European Archives of Oto-Rhino-Laryngology, 265(11), 1355.
Ryan R. A double blind clinical evaluation of bromelains in the treatment of acute sinusitis. Headache 1967;7:13-7.
Taub SJ. The use of bromelains in sinusitis: a double-blind evaluation. EENT Monthly 1967;46(3):361-5.
Seltzer AP. Adjunctive use of bromelains in sinusitis: a controlled study. EENT Monthly 1967;46(10):1281-8.
Thyme. Herbal Medicine: Expanded Commission E Monographs. American Botanical Council. 2000.
Coon JT, Ernst E. Andrographis paniculata in the treatment of upper respiratory tract infections: a systematic review of safety and efficacy. Planta Med 2004;70(4):293-8.
Cáceres DD, Hancke JL, Burgos RA, et al. Use of visual analogue scale measurements (VAS) to assess the effectiveness of standardized Andrographis paniculata extract SHA-10 in reducing the symptoms of common cold. Phytomedicine 1999;6:217-223.
Hancke J, Burgos R, Caceres D, Wikman G. A double-blind study with a new monodrug Kan Jang: Decrease of symptoms and improvement in recovery from common colds. Phytother Res 1995;9:559-62.
Melchior J, Palm S, Wikman G. Controlled clinical study of standardized Andrographis paniculata extract in common cold-a pilot trial. Phytomedicine 1996;34:315-18.
Xia YF, Ye BQ, Li YD, Wang JG, He XJ, Lin X, Yao X, Ma D, Slungaard A, Hebbel RP, Key NS, Geng JG. Andrographolide attenuates inflammation by inhibition of NF-kappa B activation through covalent modification of reduced cysteine 62 of p50. J Immunol 2004 Sep 15;173(6):4207-17.
Melchior J, Spasov AA, Ostrovskij OV, et al. Double-blind, placebo-controlled pilot and phase III study of activity of standardized Andrographis paniculata Herba Ness extract fixed combination (Kan jang) in the treatment of uncomplicated upper-respiratory tract infection. Phytomedicine 2000;7:341-50.
Gabrielian ES, Shukarian AK, Goukasova GI, et al. A double blind, placebo-controlled study of Andrographis paniculata fixed combination Kan Jang in the treatment of acute upper respiratory tract infections including sinusitis. Phytomedicine 2002;9:589-97.
WARNING: Consuming this product can expose you to chemicals including lead, which is known to the State of California to cause birth defects or other reproductive harm. For more information go to www.P65Warnings.ca.gov/food.
